Back
BioNTech SE Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
32
BNTX
BioNTech SE
Last Price:
$92.78
Seasonality Move:
25.55%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing slight buying pressure.
BioNTech SE Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 93.91 | Sell |
20-day SMA: | 100.73 | Sell |
50-day SMA: | 98.62 | Sell |
200-day SMA: | 106.45 | Sell |
8-day EMA: | 94.93 | Sell |
20-day EMA: | 97.62 | Sell |
50-day EMA: | 100.69 | Sell |
200-day EMA: | 104.76 | Sell |
BioNTech SE Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.03 | Sell |
Relative Strength Index (14 RSI): | 42.55 | Sell |
Chaikin Money Flow: | 351535 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (93.4 - 106.9) | Sell |
Bollinger Bands (100): | (96.93 - 118.39) | Sell |
BioNTech SE Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioNTech SE Stock
Is BioNTech SE Stock a Buy?
-
BioNTech SE share price is 92.34 while BNTX 8-day simple moving average is 93.91, which is a Sell signal.
-
The stock price of BNTX is 92.34 while BioNTech SE 20-day SMA is 100.73, which makes it a Sell.
-
BioNTech SE 50-day simple moving average is 98.62 while BNTX share price is 92.34, making it a Sell technically.
-
BNTX stock price is 92.34 and BioNTech SE 200-day simple moving average is 106.45, creating a Sell signal.
BNTX Technical Analysis vs Fundamental Analysis
Sell
32
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy or a Sell?
-
BioNTech SE stock is rated a SellThe current BioNTech SE [BNTX] share price is $92.34. The Score for BNTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
BioNTech SE Stock Info
Market Cap:
22.2B
Price in USD:
92.34
Share Volume:
1.2M
BioNTech SE 52-Week Range
52-Week High:
131.49
52-Week Low:
76.53
Sell
32
BioNTech SE (BNTX)
is a Sell
BioNTech SE Share Price Forecast
-
What is the BioNTech SE stock price today?The BioNTech SE stock price is 92.34 USD today.
-
Will BNTX stock go up or go down?BioNTech SE> share price is forecast to RISE/FALL based on technical indicators
-
Is BioNTech SE overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioNTech SE is overvalued.
Is BioNTech SE Stock a Buy?
-
BioNTech SE share price is 92.34 while BNTX 8-day exponential moving average is 94.93, which is a Sell signal.
-
The stock price of BNTX is 92.34 while BioNTech SE 20-day EMA is 97.62, which makes it a Sell.
-
BioNTech SE 50-day exponential moving average is 100.69 while BNTX share price is 92.34, making it a Sell technically.
-
BNTX stock price is 92.34 and BioNTech SE 200-day simple moving average is 104.76, creating a Sell signal.
Fundamental Analysis of BioNTech SE
Is BioNTech SE a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.87 per share, a decrease next quarter of $2.11 per share, a decrease this year of $2.40 per share, and an increase next year of $0.17 per share.
Technical Analysis of BioNTech SE
Should I short BioNTech SE stock?
-
BNTX Moving Average Covergence Divergence (MACD) indicator is -2.03, suggesting BioNTech SE is a Sell
-
BioNTech SE Relative Strength Index (RSI) is 42.55, which suggest BioNTech SE is oversold
-
The Bollinger Bands (25) for BioNTech SE is (93.4 - 106.9), which suggest BioNTech SE is a Sell
-
The Bollinger Bands (100) for BioNTech SE is (96.93 - 118.39), which suggest BioNTech SE is a Sell
* BioNTech SE stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.